IgGenix, Inc

📍 South San Francisco, United States🗓 Founded 2019👥 13 employees💰 Last funded Jan 2024
Biotechnology Research🌐 iggenix.com
Website LinkedIn
IgGenix is a clinical-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake’s laboratory at Stanford in collaboration with allergy clinician and researcher Kari Nadeau. We have exciting opportunities for enthusiastic, self-motivated, and highly organized individuals to join the growing team at IgGenix in South San Francisco, CA.
2
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Japan
1
Frequently asked questions
Who invested in IgGenix, Inc?
IgGenix, Inc has 2 investors on record on gritt.io, 1 mid-stage.
When did IgGenix, Inc last raise funding?
The most recent investment in IgGenix, Inc recorded on gritt.io was in January 2024.
When was IgGenix, Inc founded?
IgGenix, Inc was founded in 2019.
What industry is IgGenix, Inc in?
IgGenix, Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is IgGenix, Inc based?
IgGenix, Inc is headquartered in South San Francisco, United States.